🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

IRIS- DESyne X2 in the IRIS-DES Registry

Recruitingn/aAges 19 Years - anyAllSeung-Jung Park
NCT03588481 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study evaluates effectiveness and safety of DESyne X2 in Routine Clinical Practice.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 19 and more * Intervention with DeSyne X2 drug-eluting coronary stent * Agreed with written informed consent form Exclusion Criteria: * Intervention with DeSyne X2 drug-eluting coronary stent and other drug eluting stent at the same time * Life expectancy of 1year and under * Cardiac shock
💊

What it tests

  • DESyne X2
📍

Where

6 sites
Hallym Hospital
Incheon, South Korea
Asan Medical Hospital
Seoul, South Korea
Korea University Guro Hospital
Seoul, South Korea
The Catholic University of Korea Seoul St. Mary's Hospital
Seoul, South Korea
The Catholic University of Korea, Eunpyeong St. Mary's Hospital
Seoul, South Korea
St.carollo Hospital
Suncheon, South Korea
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy